ArriVent BioPharma Inc. C... (AVBP)
undefined
undefined%
At close: undefined
26.72
0.49%
After-hours Dec 13, 2024, 04:00 PM EST

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21
Cash & Equivalents 150.39M 163.37M 37.28M
Short-Term Investments - - -
Long-Term Investments - - 2.00K
Other Long-Term Assets 2.84M 72.00K 87.00K
Receivables 761.00K 500.00K 250.00K
Inventory -240.00K - -
Other Current Assets 9.06M 156.00K 29.00K
Total Current Assets 159.97M 182.62M 42.95M
Property-Plant & Equipment 291.00K 139.00K -
Goodwill & Intangibles - - -
Total Long-Term Assets 3.13M 211.00K 89.00K
Total Assets 163.10M 182.83M 43.04M
Account Payables 4.53M 3.09M 293.00K
Deferred Revenue - -1 -
Short-Term Debt 140.00K 128.00K -
Other Current Liabilities 6.95M 5.14M 1.52M
Total Current Liabilities 11.62M 8.36M 1.82M
Long-Term Debt 177.00K 11.00K -
Other Long-Term Liabilities - - -
Total Long-Term Liabilities 177.00K 11.00K -
Total Liabilities 11.80M 8.37M 1.82M
Total Debt 317.00K 139.00K -
Common Stock - 4.00K 4.00K
Retained Earnings -157.84M -88.51M -51.61M
Comprehensive Income - -4.00K -4.00K
Shareholders Equity 151.30M 174.46M 41.22M
Total Investments - - 2.00K